Pyridazine derivatives and their use as therapeutic agents
US7335658B2 · kind B2 · utility
32Cited by
7References
95Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2004 |
| Grant date | Feb 26, 2008 |
| Priority date | — |
| Expiry date | May 6, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D237/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.